Literature DB >> 23149498

Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can).

Björn Lindkvist1, Martin Almquist, Tone Bjørge, Tanja Stocks, Wegene Borena, Dorthe Johansen, Göran Hallmans, Anders Engeland, Gabriele Nagel, Håkan Jonsson, Randi Selmer, Guenter Diem, Christel Häggström, Steinar Tretli, Pär Stattin, Jonas Manjer.   

Abstract

PURPOSE: Little is known about the association between the metabolic syndrome (MetS) and the risk of gastric adenocarcinoma. The aim of this study was to investigate whether metabolic risk factors, together or combined, were associated with the risk of gastric adenocarcinoma.
METHODS: The Metabolic Syndrome and Cancer Project (Me-Can) is a pooling of prospective cohorts in Austria, Norway, and Sweden with information on blood pressure, lipids, glucose, and BMI available in 578,700 individuals. Cox proportional hazards analysis was used to calculate hazard ratio (HR) of gastric adenocarcinoma using metabolic risk factors categorized into quintiles and transformed into z-scores (with mean = 0 and SD = 1). The standardized sum of all z-scores created a composite MetS score.
RESULTS: In total, 1,210 incident cases of gastric adenocarcinoma were identified. Glucose was significantly associated with the risk of gastric adenocarcinoma [calibrated HR 1.58 (1.14-2.20) per one unit increment in z-score] in women. There was a statistically significant association between triglycerides and risk of gastric adenocarcinoma per mmol increment in triglycerides [HR 1.20 (1.06-1.36) per mmol] but not for the adjusted z-score in women. There were no significant association between any metabolic factors and gastric cancer among men. The composite MetS score was associated with the risk of gastric adenocarcinoma in women [HR 1.18 (1.00-1.38) per one unit increment in z-score] but not in men.
CONCLUSIONS: Glucose and high levels of the composite MetS score were associated with an increased risk of gastric adenocarcinoma in women but not in men.

Entities:  

Mesh:

Year:  2012        PMID: 23149498     DOI: 10.1007/s10552-012-0096-6

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  21 in total

1.  Gene-Lifestyle Interactions in Complex Diseases: Design and Description of the GLACIER and VIKING Studies.

Authors:  Azra Kurbasic; Alaitz Poveda; Yan Chen; Asa Agren; Elisabeth Engberg; Frank B Hu; Ingegerd Johansson; Ines Barroso; Anders Brändström; Göran Hallmans; Frida Renström; Paul W Franks
Journal:  Curr Nutr Rep       Date:  2014-12-01

2.  Genetically predicted high body mass index is associated with increased gastric cancer risk.

Authors:  Yingying Mao; Caiwang Yan; Qun Lu; Meng Zhu; Fei Yu; Cheng Wang; Juncheng Dai; Hongxia Ma; Zhibin Hu; Hongbing Shen; Guangfu Jin
Journal:  Eur J Hum Genet       Date:  2017-06-21       Impact factor: 4.246

3.  Effect of body mass index in patients undergoing resection for gastric cancer: a single center US experience.

Authors:  Joyce Wong; Shams Rahman; Nadia Saeed; Hui-Yi Lin; Khaldoun Almhanna; Ravi Shridhar; Sarah Hoffe; Kenneth L Meredith
Journal:  J Gastrointest Surg       Date:  2014-01-18       Impact factor: 3.452

4.  Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition.

Authors:  Sofia Christakoudi; Artemisia Kakourou; Georgios Markozannes; Ioanna Tzoulaki; Elisabete Weiderpass; Paul Brennan; Marc Gunter; Christina C Dahm; Kim Overvad; Anja Olsen; Anne Tjønneland; Marie-Christine Boutron-Ruault; Anne-Laure Madika; Gianluca Severi; Verena Katzke; Tilman Kühn; Manuela M Bergmann; Heiner Boeing; Anna Karakatsani; Georgia Martimianaki; Paschalis Thriskos; Giovanna Masala; Sabina Sieri; Salvatore Panico; Rosario Tumino; Fulvio Ricceri; Antonio Agudo; Daniel Redondo-Sánchez; Sandra M Colorado-Yohar; Olatz Mokoroa; Olle Melander; Tanja Stocks; Christel Häggström; Sophia Harlid; Bas Bueno-de-Mesquita; Carla H van Gils; Roel C H Vermeulen; Kay-Tee Khaw; Nicholas J Wareham; Tammy Y N Tong; Heinz Freisling; Mattias Johansson; Hannah Lennon; Dagfinn Aune; Elio Riboli; Dimitrios Trichopoulos; Antonia Trichopoulou; Konstantinos K Tsilidis
Journal:  Int J Cancer       Date:  2019-08-20       Impact factor: 7.396

Review 5.  Influence of metabolic syndrome on upper gastrointestinal disease.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Tetsuo Kimura; Koichi Okamoto; Hiroshi Miyamoto; Naoki Muguruma; Tetsuji Takayama
Journal:  Clin J Gastroenterol       Date:  2016-07-02

6.  The association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomy.

Authors:  Gui-Ming Zhang; Yao Zhu; Da-Hai Dong; Cheng-Tao Han; Cheng-Yuan Gu; Wei-Jie Gu; Xiao-Jian Qin; Li-Jiang Sun; Ding-Wei Ye
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

Review 7.  Metabolic syndrome and renal cell carcinoma.

Authors:  Gui-Ming Zhang; Yao Zhu; Ding-Wei Ye
Journal:  World J Surg Oncol       Date:  2014-07-29       Impact factor: 2.754

8.  Preoperative Body Mass Index, Blood Albumin and Triglycerides Predict Survival for Patients with Gastric Cancer.

Authors:  Bin Zheng Liu; Lin Tao; Yun Zhao Chen; Xu Zhe Li; Yu Ling Dong; Ya Jing Ma; Shu Gang Li; Feng Li; Wen Jie Zhang
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

9.  Preoperative Metabolic Syndrome Is Predictive of Significant Gastric Cancer Mortality after Gastrectomy: The Fujian Prospective Investigation of Cancer (FIESTA) Study.

Authors:  Dan Hu; Feng Peng; Xiandong Lin; Gang Chen; Hejun Zhang; Binying Liang; Kaida Ji; Jinxiu Lin; Lin-Feng Chen; Xiongwei Zheng; Wenquan Niu
Journal:  EBioMedicine       Date:  2016-12-07       Impact factor: 8.143

Review 10.  Abdominal obesity and gastroesophageal cancer risk: systematic review and meta-analysis of prospective studies.

Authors:  Xuan Du; Khemayanto Hidayat; Bi-Min Shi
Journal:  Biosci Rep       Date:  2017-05-11       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.